期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
无痛胃镜检查时布托啡诺抑制吞咽反射ED50和ED95的测定 被引量:7
1
作者 胡君凤 胡双燕 +4 位作者 仲俊峰 叶钢 毛琳玲 邱凯 陈栋樑 《中国内镜杂志》 2022年第2期63-67,共5页
目的测定不同剂量丙泊酚复合布托啡诺无痛胃镜检查时,布托啡诺抑制吞咽反射的ED50和ED95值。方法将76例无痛胃镜检查患者随机分为P1组和P2组,P1组给予丙泊酚2.0 mg/kg复合布托啡诺静脉麻醉,P2组给予2.5 mg/kg丙泊酚复合布托啡诺静脉麻... 目的测定不同剂量丙泊酚复合布托啡诺无痛胃镜检查时,布托啡诺抑制吞咽反射的ED50和ED95值。方法将76例无痛胃镜检查患者随机分为P1组和P2组,P1组给予丙泊酚2.0 mg/kg复合布托啡诺静脉麻醉,P2组给予2.5 mg/kg丙泊酚复合布托啡诺静脉麻醉。布托啡诺初始剂量为5.0μg/kg,根据吞咽反射抑制情况,运用Dixon序贯法确定下一例患者使用剂量,应用Probit分析得出两组患者布托啡诺抑制吞咽反射ED50和ED95值。结果P2组低血压发生率明显高于P1组(P<0.05);P1组和P2组布托啡诺抑制吞咽反射的ED50分别为3.5μg/kg(95%CI:2.9~4.1)和3.1μg/kg(95%CI:2.4~3.5);P1组和P2组抑制吞咽反射的ED95分别为5.8μg/kg(95%CI:4.7~15.9)和5.0μg/kg(95%CI:4.1~12.3)。结论布托啡诺复合丙泊酚2.0和2.5 mg/kg无痛胃镜检查时,抑制吞咽反射的ED50分别为3.5和3.1μg/kg,ED95分别为5.8和5.0μg/kg,对临床无痛胃镜麻醉用药具有指导意义。 展开更多
关键词 布托啡诺 ED50 ED95 胃镜 吞咽反射
下载PDF
p38αMAP kinase promotes asthmatic inflammation through modulation of alternatively activated macrophages 被引量:3
2
作者 Li-Nian huang Lei Sun +7 位作者 Li-Ming Liu hui-hui Zhang Zhong-Bo Liang Yan Rui jun-feng hu Yong Zhang John WChristman Feng Qian 《Journal of Molecular Cell Biology》 SCIE CAS CSCD 2019年第12期1095-1097,共3页
Asthma is characterized by reversible airflow obstruction, bronchial hyper-reactivity, and chronic airway remodeling (Al-Muhsen et al., 2011). Pulmonary macrophages have been implicated in asthmatic inflammation (Lee ... Asthma is characterized by reversible airflow obstruction, bronchial hyper-reactivity, and chronic airway remodeling (Al-Muhsen et al., 2011). Pulmonary macrophages have been implicated in asthmatic inflammation (Lee et al., 2015;Qian et al., 2015). The p38 mitogen-activated protein kinase (MAPK) plays an essential role in inflammation, but its role in asthma has not been determined (Kim et al., 2008). Here, our data show that macrophage-specific p38α MAPK-deficient mice displayed attenuated asthmatic inflammation in response to three allergens (dust mite, ragweed, and Aspergillus;DRA). Furthermore, we found that the protective effect was strongly associated with a reduction in the alternatively activated macrophage (AAM) polarization in vivo and in vitro. Taken together, our data indicate that p38α MAPK in macrophages contributes to AAM polarization and could be a therapeutic target for asthma. 展开更多
关键词 INFLAMMATION al. ASTHMA
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部